EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Emerging Biomarkers and Advanced Diagnostics in Chronic Kidney Disease: Early Detection Through Multi-Omics and AI

Sami Alobaidi iD

Diagnostics · 13.05.2025 · 15 (10) · 1225

DOI: 10.3390/diagnostics15101225 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 13.05.2025. Verfasst von Sami Alobaidi. Beteiligte Einrichtung: Department of Internal Medicine, University of Jeddah, Jeddah 21493, Saudi Arabia. Die Arbeit wurde bisher 87-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease (CKD) remains a significant global health burden, often diagnosed at advanced stages due to the limitations of traditional biomarkers such as serum creatinine and estimated glomerular filtration rate (eGFR). This review aims to critically evaluate recent advancements in novel biomarkers, multi-omics technologies, and artificial intelligence (AI)-driven diagnostic strategies, specifically addressing existing gaps in early CKD detection and personalized patient management. We specifically explore key advancements in CKD diagnostics, focusing on emerging biomarkers—including neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), soluble urokinase plasminogen activator receptor (suPAR), and cystatin C—and their clinical applications. Additionally, multi-omics approaches integrating genomics, proteomics, metabolomics, and transcriptomics are reshaping disease classification and prognosis. Artificial intelligence (AI)-driven predictive models further enhance diagnostic accuracy, enabling real-time risk assessment and treatment optimization. Despite these innovations, challenges remain in biomarker standardization, large-scale validation, and integration into clinical practice. Future research should focus on refining multi-biomarker panels, improving assay standardization, and facilitating the clinical adoption of precision-driven diagnostics. By leveraging these advancements, CKD diagnostics can transition toward earlier intervention, individualized therapy, and improved patient outcomes.

Schlagwörter

Stichwörter der Autor:innen

AI-driven diagnosticsCKD risk predictionchronic kidney diseaseemerging biomarkersgenomicsmetabolomicspersonalized nephrologyproteomics

Autor:innen und Institutionen

  • Department of Internal Medicine, University of Jeddah, Jeddah 21493, Saudi Arabia.

ORCID-Profile: Sami Alobaidi

Zitieren

APA

Alobaidi, S. (2025). Emerging Biomarkers and Advanced Diagnostics in Chronic Kidney Disease: Early Detection Through Multi-Omics and AI. Diagnostics, 15(10), 1225. https://doi.org/10.3390/diagnostics15101225

Vancouver

Alobaidi S. Emerging Biomarkers and Advanced Diagnostics in Chronic Kidney Disease: Early Detection Through Multi-Omics and AI. Diagnostics. 2025;15(10):1225. doi:10.3390/diagnostics15101225

BibTeX
@article{Alobaidi2025,
  author = {Alobaidi, Sami},
  title = {Emerging Biomarkers and Advanced Diagnostics in Chronic Kidney Disease: Early Detection Through Multi-Omics and AI},
  journal = {Diagnostics},
  year = {2025},
  volume = {15},
  number = {10},
  pages = {1225},
  doi = {10.3390/diagnostics15101225}
}
Kostenlos starten →